RGPR mutant ad.jpg

We currently have no specific openings in Mill lab but we are always looking for driven, enthusiastic and talented team members, so drop us a line with your CV and specific interests in our research.

My Post-8.jpg

MRC funded 4yr PhD studentship in Human Genetics, Genomics and Disease

We will be looking for enthusiastic and driven candidates to join us as one of 8 successful PhD intakes for 2020. It is a very multidisciplinary PhD programme encompassing high quality training, mentorship and research excellence to prepare you to tackle the most challenging questions underpinning health and disease. Importantly, it offers students the opportunity to participate participate in 3 mini-projects to experience different laboratory or computational environment, ahead of selecting their thesis project. There is also a structured teaching element covering key topics in areas such as genome regulation, disease mechanisms and biomedical genomics, plus computational and statistical training. Come join us! Our 2020 studentship round call will reopen in late 2019, but you can contact us in advance to discuss project and possibilities.

Our studentship project this year is Defining cell-type specific molecular repair signatures during therapeutic genome editing. The recent game-changer for genetic disease is the utilization of CRISPR technology for human genome editing, thus offering a possible cure for genetic diseases. There are, however, sizeable obstacles to making this a therapeutic reality, including (a) targeted delivery of editing machinery and (b) improving repair efficiency. To fast-track solutions to these problems, we developed powerful fluorescent reporter mouse models, allowing sensitive read-outs of genome-editing. In this studentship, you will determine whether differences in DNA repair pathways exist in different cell types and/or at different stages of differentiation, and whether these change with different delivery systems. You will help determine the most effective formulation for establishing therapeutically-beneficial editing in vivo. Contact us if you’d like to discuss it more.